Zobrazeno 1 - 10 of 1 478 pro vyhledávání: '"Iezzi, S."'
1
Akademický článek
Immunotherapy in melanoma: advances, pitfalls, and future perspectives.
Autor: Sorino C; SAFU, Department of Research, Advanced Diagnostics, and Technological Innovation, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Iezzi S; SAFU, Department of Research, Advanced Diagnostics, and Technological Innovation, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Ciuffreda L; SAFU, Department of Research, Advanced Diagnostics, and Technological Innovation, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Falcone I; SAFU, Department of Research, Advanced Diagnostics, and Technological Innovation, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
Publikováno v: Frontiers in molecular biosciences [Front Mol Biosci] 2024 Jun 28; Vol. 11, pp. 1403021. Date of Electronic Publication: 2024 Jun 28 (Print Publication: 2024).
Zobrazit plný text záznamu
2
Akademický článek
HAX1 is a novel binding partner of Che-1/AATF. Implications in oxidative stress cell response.
Autor: Pisani C; CNR-Institute of Molecular Biology and Pathology, Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161 Rome, Italy. Electronic address: cinzia.pisani@cnr.it., Onori A; CNR-Institute of Molecular Biology and Pathology, Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161 Rome, Italy., Gabanella F; CNR-Institute of Biochemistry and Cell Biology, Department of Sense Organs, Sapienza University of Rome, Viale del Policlinico 155, 00161 Rome, Italy., Iezzi S; SAFU Unit, Department of Research and Advanced Technologies, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy., De Angelis R; ISPRA, Italian National Institute for Environmental Protection and Research, Via Vitaliano Brancati 48, 00144 Rome, Italy., Fanciulli M; SAFU Unit, Department of Research and Advanced Technologies, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy., Colizza A; Department of Sense Organs, Sapienza University of Rome, Viale del Policlinico 155, 00161 Rome, Italy., de Vincentiis M; Department of Sense Organs, Sapienza University of Rome, Viale del Policlinico 155, 00161 Rome, Italy., Di Certo MG; CNR-Institute of Biochemistry and Cell Biology, Department of Sense Organs, Sapienza University of Rome, Viale del Policlinico 155, 00161 Rome, Italy., Passananti C; CNR-Institute of Molecular Biology and Pathology, Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161 Rome, Italy. Electronic address: claudio.passananti@cnr.it., Corbi N; CNR-Institute of Molecular Biology and Pathology, Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161 Rome, Italy. Electronic address: nicoletta.corbi@cnr.it.
Publikováno v: Biochimica et biophysica acta. Molecular cell research [Biochim Biophys Acta Mol Cell Res] 2024 Jan; Vol. 1871 (1), pp. 119587. Date of Electronic Publication: 2023 Sep 22.
Zobrazit plný text záznamu
3
Periodical
BOVINOS MACHOS JÓVENES CASTRADOS VERSUS ENTEROS: CALIDAD DE CARNE Y PROPIEDADES DEL TEJIDO CONECTIVO.
Autor: Latorre, M. E.1 latorre.emilia@gmail.com, Iezzi, S.1,2, Christensen, S.1,3, Purslow, P. P.3
Publikováno v: Alimentacion Latinoamericana. ago2018, Issue 338, p52-58. 7p.
Zobrazit plný text záznamu
4
Akademický článek
AATF/Che-1 RNA polymerase II binding protein overexpression reduces the anti-tumor NK-cell cytotoxicity through activating receptors modulation.
Autor: Caforio M; Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Tumino N; Immunology Research Area, Innate Lymphoid Cells Unit, Bambino Gesù Children's Hospital Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Sorino C; Stabilimento Allevamento Fornitore e Utilizzatore (SAFU) Laboratory, Department of Research, Advanced Diagnostic, Technological Innovation, Regina Elena National Cancer Institute Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Manni I; Stabilimento Allevamento Fornitore e Utilizzatore (SAFU) Laboratory, Department of Research, Advanced Diagnostic, Technological Innovation, Regina Elena National Cancer Institute Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Di Giovenale S; Stabilimento Allevamento Fornitore e Utilizzatore (SAFU) Laboratory, Department of Research, Advanced Diagnostic, Technological Innovation, Regina Elena National Cancer Institute Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Piaggio G; Stabilimento Allevamento Fornitore e Utilizzatore (SAFU) Laboratory, Department of Research, Advanced Diagnostic, Technological Innovation, Regina Elena National Cancer Institute Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Iezzi S; Stabilimento Allevamento Fornitore e Utilizzatore (SAFU) Laboratory, Department of Research, Advanced Diagnostic, Technological Innovation, Regina Elena National Cancer Institute Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Strimpakos G; National Research Council (CNR), Institute of Biochemistry and Cell Biology, Monterotondo, Rome, Italy., Mattei E; Consiglio Nazionale delle Ricerche (CNR)-Institute of Cell Biology and Neurobiology, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Fondazione Santa Lucia, Rome, Italy., Moretta L; Tumor Immunology Unit , Children Hospital Bambino Gesù, RomaLM, Rome, Italy., Fanciulli M; Stabilimento Allevamento Fornitore e Utilizzatore (SAFU) Laboratory, Department of Research, Advanced Diagnostic, Technological Innovation, Regina Elena National Cancer Institute Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Vacca P; Immunology Research Area, Innate Lymphoid Cells Unit, Bambino Gesù Children's Hospital Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Locatelli F; Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy.; Department of Life Sciences and Public Health, Catholic University of the Sacred Heart, Rome, Italy., Folgiero V; Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
Publikováno v: Frontiers in immunology [Front Immunol] 2023 Jun 26; Vol. 14, pp. 1191908. Date of Electronic Publication: 2023 Jun 26 (Print Publication: 2023).
Zobrazit plný text záznamu
5
Akademický článek
Che-1 activates XIAP expression in response to DNA damage.
Autor: Bruno, T.1, Iezzi, S.1, De Nicola, F.1, Di Padova, M.2, Desantis, A.2, Scarsella, M.3, Di Certo, M. G.2,4, Leonetti, C.3, Floridi, A.1,2, Passananti, C.5,6, Fanciulli, M.1,6 fanciulli@.ifo.it
Publikováno v: Cell Death & Differentiation. Mar2008, Vol. 15 Issue 3, p515-520. 6p. 2 Black and White Photographs, 2 Graphs.
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia
Autor: Folgiero, V, and Sorino, C, and Pallocca, M, and De Nicola, F, and Goeman, F, and Bertaina, V, and Strocchio, L, Romania, P, and Pitisci, A, and Iezzi, S, And, Catena, V, and Bruno, T, and Strimpakos, G, And, Passananti, C, and Mattei, E, and Blandino, G, And, Locatelli, F and Fanciulli, M.
Publikováno v: EMBO reports
Volume 19 (2018). doi:10.15252/embr.201744871
info:cnr-pdr/source/autori:Folgiero V, Sorino C, Pallocca M, De Nicola F, Goeman F, Bertaina V, Strocchio L, Romania P, Pitisci A, Iezzi S, Catena V, Bruno T, Strimpakos G, Passananti C, Mattei E, Blandino G, Locatelli F, Fanciulli M./titolo:Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia/doi:10.15252%2Fembr.201744871/rivista:EMBO reports (Print)/anno:2018/pagina_da:/pagina_a:/intervallo_pagine:/volume:Volume 19
Despite progress in treating B‐cell precursor acute lymphoblastic leukemia (BCP‐ALL), disease recurrence remains the main cause of treatment failure. New strategies to improve therapeutic outcomes are needed, particularly in high‐risk relapsed
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b24ff469e47486960d5513f4a0d84dad
http://embor.embopress.org/content/early/2018/01/24/embr.201744871
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
CK2-mediated phosphorylation of Che-1/AATF is required for its pro-proliferative activity.
Autor: Catena V; SAFU Laboratory, Department of Research, Advanced Diagnostics and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via E. Chianesi 53, 00144, Rome, Italy. valeria.catena@ifo.gov.it., Bruno T; SAFU Laboratory, Department of Research, Advanced Diagnostics and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via E. Chianesi 53, 00144, Rome, Italy., Iezzi S; SAFU Laboratory, Department of Research, Advanced Diagnostics and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via E. Chianesi 53, 00144, Rome, Italy., Matteoni S; Unit of Cellular Networks and Molecular Therapeutic Targets, Department of Research, Advanced Diagnostics and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via E. Chianesi 53, 00144, Rome, Italy., Salis A; Department of Experimental Medicine (DIMES), Biochemistry Section, University of Genoa, Viale Benedetto XV 1, 16132, Genoa, Italy., Sorino C; SAFU Laboratory, Department of Research, Advanced Diagnostics and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via E. Chianesi 53, 00144, Rome, Italy., Damonte G; Department of Experimental Medicine (DIMES), Biochemistry Section, University of Genoa, Viale Benedetto XV 1, 16132, Genoa, Italy., Fanciulli M; SAFU Laboratory, Department of Research, Advanced Diagnostics and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via E. Chianesi 53, 00144, Rome, Italy. maurizio.fanciulli@ifo.gov.it.
Publikováno v: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2021 Jul 15; Vol. 40 (1), pp. 232. Date of Electronic Publication: 2021 Jul 15.
Zobrazit plný text záznamu
10
Akademický článek
Molecular insights unlocking therapeutic potential for multiple myeloma and bone disease management.
Autor: Bruno, Tiziana1 (AUTHOR), Catena, Valeria1 (AUTHOR), Blandino, Giovanni2 (AUTHOR), Fanciulli, Maurizio1 (AUTHOR), Di Agostino, Silvia3 (AUTHOR) sdiagostino@unicz.it
Publikováno v: Journal of Experimental & Clinical Cancer Research (17569966). 12/18/2024, Vol. 43 Issue 1, p1-4. 4p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje